Scott Daniel Cormack, President and CEO at ONCOGENEX PHARMACEUTICALS, INC. (OGXI), sold 7,543 shares at $1.88 ($14K) on 2015-05-20, disclosed to the SEC on 2015-05-21.
Open-market sale of $14k OGXI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OGXI | SELL | 2015-06-16 | $12K | — | Filing → |
| OGXI | SELL | 2014-08-14 | $58K | — | Filing → |
| OGXI | SELL | 2014-03-18 | $57K | — | Filing → |